2Flam E,Berry S,Coyle A,et al.Blood-flow augmentation of intermittent pneumatic compression systems used for prevention of deep vein thrombosis prior to surgery[J].Am J Surg,1996,171(3):312-315.
3Wang WZ,Fang XH,Stepheson LL,et al.NOS upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle[J].J Orthop Res,2004,22(3):578-585.
7Lieberman JR,Hsu WK.Prevention of venous thromboembolic disease after total hip and knee arthroplasty[J].J Bone Joint Surg Am,2005,87(9):2097-2112.
8Warkentin TE,Greinacher A.Heparin-induced thrombocytopenia:recognition,treatment,and prevention:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126(3 Suppl):311-337.
9Petitou M,Duchaussoy P,Herbert JM,et al.The synthetic pentasaccharide fondaparinux:first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa[J].Semin Thromb Hemost,2002,28(4):393-402.
10Warkentin TE,Cook RJ,Marder VJ,et al.Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin[J].Blood,2005,106(12):3791-3796.
2Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): 338-400.
3Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation, 2003, 107(23 Suppl 1): 9-16.
4Liew NC, Moissinac K, Gul Y. Postoperative venous thromboembolism in Asia: a critical appraisal of its incidence. Asian J Surg,2003, 26: 154-158.
5Geerts WH, Heir JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001, 119(1 Suppl): 132-175.
6Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med, 2002, 162: 1833-1840.
7Fitzgerald RH Jr, Spiro TE, Trowbridge AA, et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. J Bone Joint Surg(Am), 2001, 83: 900-906.
8Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest, 2003, 124(6 Suppl): 386-392.
9O'Donnell M, Linkins LA, Kearon C, et al. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review. Arch Intern Med, 2003, 163:1362-1366.
10Samama CM, Vray M, Barre J, et al. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of lowmolecular-weight heparin with oral anticoagulant. Arch Intern Med,2002, 162: 2191-2196.
